Migraine
Not recruitingStudy on Atogepant for Preventing Menstrual Migraine in Women
Study on Atogepant for Preventing Menstrual Migraine in Women
Germany- Participants:18–64 years
- Substances:Atogepant
- Sponsor:Abbvie Deutschland GmbH & Co. KG
Rare diseases
Investigational molecules
Locations
Back to Germany329 clinical trials in Bad Oeynhausen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Atogepant for Preventing Menstrual Migraine in Women
GermanyStudy on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy
GermanyStudy on PRAX-628 for Adults with Focal Onset or Generalized Tonic-Clonic Seizures
GermanyStudy on the Safety and Effectiveness of Fedratinib and Azacitidine for Patients with Accelerated Phase Myelofibrosis
GermanyStudy of Gandotinib for Patients with Myeloproliferative Neoplasms, Myelofibrosis, Essential Thrombocythemia, or Polycythemia Vera
GermanyStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
GermanyStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
GermanyStudy on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
GermanyStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
GermanyStudy on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder
GermanyStudy on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery
GermanyStudy of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for heart failure and cardiovascular disease, including studies of novel compounds like baxdrostat and pelacarsen to reduce major cardiovascular events.
Advanced diagnostic approaches including PET imaging for coronary conditions.
Comprehensive research focusing on Type 2 Diabetes management and its complications, including studies on innovative treatments for diabetic peripheral neuropathy.
Novel therapeutic approaches for hypercholesterolemia and weight management.
Ground-breaking research in chronic kidney disease treatment, particularly focusing on complications associated with diabetes and hypertension.
Innovative therapies targeting kidney function preservation and disease progression.
Advanced research in hypertrophic cardiomyopathy and cardiac structural conditions, including maternal-fetal cardiac development studies.
Targeted therapies for specific cardiac conditions and preventive interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.